General Incorporated Association Medical Development Institute Information on the 41st SMD Seminar

Information on the 41st SMD Seminar of the National Institute for Medical Development ​
General Incorporated Association Medical Development Institute Press release: November 12, 2024 Information on the 41st SMD Seminar This is a seminar series on drug development and prescription provided as part of the SMD (Specialist in Medicines Development) international certification course.
https://prcdn.freetls.fastly.net/release_image/114508/35/114508-35-3c5c6e588d3777c363186daff3957023-569×566.jpg

Date and time: Monday, November 18, 2024 18:30 – 19:30 Lecturers: Kosuke Yoshida (Linical Co., Ltd.), Yasunari Hamasaki (GlaxoSmithKline Co., Ltd.) Theme: Drug lag and drug loss (Part 2) Summary: At the first seminar, Mr. Hamasaki explained the history and problems of drug lag and drug loss. In the second session, we will discuss what is required from the perspective of public health (cost and
effectiveness) regarding the state of pharmaceuticals and medical devices in insurance medical care in Japan, based on the past history and current issues. I would like to have a discussion with you all. Participation fee: Free Pre-application:
https://forms.gle/ck9GCJ97eoRe5BkG9 Access URL on the day: Will be notified on the pre-registration screen.